Safety and Tolerability of the BNT162b2 mRNA COVID-19 Vaccine in Dialyzed Patients. COViNEPH Project

Background and Objectives: The Pfizer-BioNTech (BNT162b2) COVID-19 mRNA vaccine has demonstrated excellent efficacy and safety in phase 3 trials. However, no dialyzed patients were included, and therefore safety data for this patient group is lacking. The aim of the study was to assess the safety an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Medicina (Kaunas)
Main Authors: Polewska, Karolina, Tylicki, Piotr, Biedunkiewicz, Bogdan, Rucińska, Angelika, Szydłowska, Aleksandra, Kubanek, Alicja, Rosenberg, Iwona, Rodak, Sylwia, Ślizień, Waldemar, Renke, Marcin, Dębska-Ślizień, Alicja, Tylicki, Leszek
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8307559/
https://ncbi.nlm.nih.gov/pubmed/34357013
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/medicina57070732
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados